You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FYREMADEL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Fyremadel, and what generic alternatives are available?

Fyremadel is a drug marketed by Sun Pharm and is included in one NDA.

The generic ingredient in FYREMADEL is ganirelix acetate. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ganirelix acetate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Fyremadel

A generic version of FYREMADEL was approved as ganirelix acetate by ORGANON USA ORGANON on July 29th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FYREMADEL?
  • What are the global sales for FYREMADEL?
  • What is Average Wholesale Price for FYREMADEL?
Summary for FYREMADEL
Drug patent expirations by year for FYREMADEL
Drug Prices for FYREMADEL

See drug prices for FYREMADEL

US Patents and Regulatory Information for FYREMADEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm FYREMADEL ganirelix acetate INJECTABLE;INJECTION 204246-001 Nov 30, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.